Title: Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.
Journal: Bioorganic & medicinal chemistry 20100215
Title: FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro.
Journal: Cancer research 20090401
Title: Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
Journal: The Journal of allergy and clinical immunology 20060801
Title: Effects of the protein tyrosine kinase inhibitor, SU5614, on leukemic and normal stem cells.
Journal: Haematologica 20051101
Title: In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia.
Journal: Leukemia research 20050901
Title: Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.
Journal: The Journal of allergy and clinical immunology 20041101
Title: Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production.
Journal: The Journal of biological chemistry 20040716
Title: Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK.
Journal: American journal of physiology. Heart and circulatory physiology 20040501
Title: Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells.
Journal: Blood 20040315
Title: Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor.
Journal: Blood 20030715
Title: Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030601
Title: A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Journal: The Journal of laboratory and clinical medicine 20030301
Title: The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.
Journal: Blood 20030215
Title: Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.
Journal: Medical oncology (Northwood, London, England) 20030101
Title: A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia.
Journal: Blood 20021101
Title: SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.
Journal: Blood 20021015
Title: The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Journal: Experimental hematology 20020701
Title: Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20020401
Title: The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
Journal: Radiation research 20020101
Title: Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow.
Journal: Growth factors (Chur, Switzerland) 20010101
